The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
Video: Morningstar's Christine Benz speaks with Vanguard founder Jack Bogle about how investors s...
Banking, mining and oil sectors are driving the returns so far in 2025.
Shares of the Stuttgart-based car manufacturer continue to be undervalued.
What economist Ben Graham’s dictum can tell us about stock market behavior after the latest presi...
These stocks all have attractive yields and valuations.
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Banking, mining and oil sectors are driving the returns so far in 2025.
Shares of the Stuttgart-based car manufacturer continue to be undervalued.
What economist Ben Graham’s dictum can tell us about stock market behavior after the latest presi...
These stocks all have attractive yields and valuations.
Move over, Novo Nordisk and Eli Lilly. Why Pfizer and Roche look like top choices for investors.
Christopher J. Traulsen, CFA is director of fund research, Europe and Asia, Morningstar.